New Therapeutic Approaches for Allergy: A Review of Cell Therapy and Bio- or Nano-Material-Based Strategies

dc.contributor.authorParis, Juan L.
dc.contributor.authorde la Torre, Paz
dc.contributor.authorFlores, Ana I.
dc.contributor.authoraffiliation[Paris, Juan L.] Inst Invest Biomed Malaga IBIMA, Allergy Res Grp, Malaga 29010, Spain
dc.contributor.authoraffiliation[Paris, Juan L.] Andalusian Ctr Nanomed & Biotechnol BIONAND, Malaga 29590, Spain
dc.contributor.authoraffiliation[de la Torre, Paz] Inst Invest Sanitaria Hosp 12 Octubre imas12, Grp Med Regenerat, Madrid 28041, Spain
dc.contributor.authoraffiliation[Flores, Ana I.] Inst Invest Sanitaria Hosp 12 Octubre imas12, Grp Med Regenerat, Madrid 28041, Spain
dc.contributor.funderInstituto de Salud Carlos III (ISCIII), Ministry of Economy, Industry, and Competitiveness
dc.contributor.funderEuropean Regional Development Fund
dc.contributor.funderFundacion Francisco Soria Melguizo
dc.contributor.funderISCIII
dc.contributor.funderEuropean Social Fund ("El FSE invierte en futuro")
dc.date.accessioned2025-01-07T13:12:47Z
dc.date.available2025-01-07T13:12:47Z
dc.date.issued2021-12-01
dc.description.abstractAllergy constitutes a major health issue due to its large prevalence. The established therapeutic approaches (allergen avoidance, antihistamines, and corticosteroids) do not address the underlying causes of the pathology, highlighting the need for other long-term treatment options. Antigen-specific immunotherapy enables the long-term control of allergic diseases by promoting immunological tolerance to the allergen. However, efficacious immunotherapies are not available for all possible allergens, and the risk of undesired reactions during therapy remains a concern, especially in patients with severe allergic reactions. In this context, two types of therapeutic strategies appear especially promising for the future in the context of allergy: cell therapy and bio- or nano-material-based therapy. In this review, the main strategies developed this far in these two types of strategies are discussed, with several examples illustrating the different approaches.
dc.identifier.doi10.3390/pharmaceutics13122149
dc.identifier.essn1999-4923
dc.identifier.pmid34959429
dc.identifier.unpaywallURLhttps://www.mdpi.com/1999-4923/13/12/2149/pdf?version=1639479173
dc.identifier.urihttps://hdl.handle.net/10668/25333
dc.identifier.wosID736810300001
dc.issue.number12
dc.journal.titlePharmaceutics
dc.journal.titleabbreviationPharmaceutics
dc.language.isoen
dc.organizationInstituto de Investigación Biomédica de Málaga - Plataforma Bionand (IBIMA)
dc.organizationInstituto de Investigación Biomédica de Málaga - Plataforma Bionand (IBIMA)
dc.publisherMdpi
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectallergy
dc.subjectcell therapy
dc.subjectbiomaterials
dc.subjectnano-materials
dc.subjectimmunotherapy
dc.subjectRegulatory t-cells
dc.subjectB-cells
dc.subjectDendritic cells
dc.subjectMast-cell
dc.subjectAirway inflammation
dc.subjectImmune tolerance
dc.subjectFood allergy
dc.subjectImmunotherapy
dc.subjectResponses
dc.subjectExosomes
dc.titleNew Therapeutic Approaches for Allergy: A Review of Cell Therapy and Bio- or Nano-Material-Based Strategies
dc.typereview
dc.type.hasVersionVoR
dc.volume.number13
dc.wostypeReview

Files